cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-094 Vyclo

A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML

Promotor Name : Janssen

Investigator Name : M. ZWAAN

Trial registered on clinicaltrial.gov :